Click for best price
Melanoma Molecular Diagnostics Market Size, Share 2023
A molecular approach for diagnosing melanoma
This report aims to provide a comprehensive presentation of the global market for Melanoma Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melanoma Molecular Diagnostics. This report contains market size and forecasts of Melanoma Molecular Diagnostics in global, including the following market information:
Global Melanoma Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Melanoma Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Melanoma Molecular Diagnostics include Foundationmendicine, Novartis, Mole, Berryoncology, Gene+, Annoroad, Topgen, Geneis and Unitedgene, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Melanoma Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melanoma Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Melanoma Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Melanoma Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Melanoma Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Melanoma Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Melanoma Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melanoma Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Melanoma Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Foundationmendicine
Novartis
Mole
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Unitedgene
Inmedi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Melanoma Molecular Diagnostics, market overview.
Chapter 2: Global Melanoma Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Melanoma Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Melanoma Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Melanoma Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Melanoma Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Melanoma Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Melanoma Molecular Diagnostics Overall Market Size
2.1 Global Melanoma Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Melanoma Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Melanoma Molecular Diagnostics Players in Global Market
3.2 Top Global Melanoma Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Melanoma Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Melanoma Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Melanoma Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Melanoma Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Melanoma Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Melanoma Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Melanoma Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Melanoma Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Melanoma Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Melanoma Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Melanoma Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Melanoma Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Melanoma Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Melanoma Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Melanoma Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Melanoma Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Melanoma Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Melanoma Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Melanoma Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Melanoma Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Melanoma Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Melanoma Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Melanoma Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Melanoma Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Melanoma Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Melanoma Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Melanoma Molecular Diagnostics Market Size, 2018-2030
7 Melanoma Molecular Diagnostics Companies Profiles
7.1 Foundationmendicine
7.1.1 Foundationmendicine Company Summary
7.1.2 Foundationmendicine Business Overview
7.1.3 Foundationmendicine Melanoma Molecular Diagnostics Major Product Offerings
7.1.4 Foundationmendicine Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Foundationmendicine Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Melanoma Molecular Diagnostics Major Product Offerings
7.2.4 Novartis Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Mole
7.3.1 Mole Company Summary
7.3.2 Mole Business Overview
7.3.3 Mole Melanoma Molecular Diagnostics Major Product Offerings
7.3.4 Mole Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Mole Key News & Latest Developments
7.4 Berryoncology
7.4.1 Berryoncology Company Summary
7.4.2 Berryoncology Business Overview
7.4.3 Berryoncology Melanoma Molecular Diagnostics Major Product Offerings
7.4.4 Berryoncology Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Berryoncology Key News & Latest Developments
7.5 Gene+
7.5.1 Gene+ Company Summary
7.5.2 Gene+ Business Overview
7.5.3 Gene+ Melanoma Molecular Diagnostics Major Product Offerings
7.5.4 Gene+ Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Gene+ Key News & Latest Developments
7.6 Annoroad
7.6.1 Annoroad Company Summary
7.6.2 Annoroad Business Overview
7.6.3 Annoroad Melanoma Molecular Diagnostics Major Product Offerings
7.6.4 Annoroad Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Annoroad Key News & Latest Developments
7.7 Topgen
7.7.1 Topgen Company Summary
7.7.2 Topgen Business Overview
7.7.3 Topgen Melanoma Molecular Diagnostics Major Product Offerings
7.7.4 Topgen Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Topgen Key News & Latest Developments
7.8 Geneis
7.8.1 Geneis Company Summary
7.8.2 Geneis Business Overview
7.8.3 Geneis Melanoma Molecular Diagnostics Major Product Offerings
7.8.4 Geneis Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Geneis Key News & Latest Developments
7.9 Unitedgene
7.9.1 Unitedgene Company Summary
7.9.2 Unitedgene Business Overview
7.9.3 Unitedgene Melanoma Molecular Diagnostics Major Product Offerings
7.9.4 Unitedgene Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Unitedgene Key News & Latest Developments
7.10 Inmedi
7.10.1 Inmedi Company Summary
7.10.2 Inmedi Business Overview
7.10.3 Inmedi Melanoma Molecular Diagnostics Major Product Offerings
7.10.4 Inmedi Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Inmedi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Melanoma Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Melanoma Molecular Diagnostics Market Drivers in Global Market
Table 3. Melanoma Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Melanoma Molecular Diagnostics in Global Market
Table 5. Top Melanoma Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Melanoma Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Melanoma Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Melanoma Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Melanoma Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Melanoma Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Melanoma Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Melanoma Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Foundationmendicine Company Summary
Table 31. Foundationmendicine Melanoma Molecular Diagnostics Product Offerings
Table 32. Foundationmendicine Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Foundationmendicine Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Melanoma Molecular Diagnostics Product Offerings
Table 36. Novartis Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Mole Company Summary
Table 39. Mole Melanoma Molecular Diagnostics Product Offerings
Table 40. Mole Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Mole Key News & Latest Developments
Table 42. Berryoncology Company Summary
Table 43. Berryoncology Melanoma Molecular Diagnostics Product Offerings
Table 44. Berryoncology Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Berryoncology Key News & Latest Developments
Table 46. Gene+ Company Summary
Table 47. Gene+ Melanoma Molecular Diagnostics Product Offerings
Table 48. Gene+ Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Gene+ Key News & Latest Developments
Table 50. Annoroad Company Summary
Table 51. Annoroad Melanoma Molecular Diagnostics Product Offerings
Table 52. Annoroad Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Annoroad Key News & Latest Developments
Table 54. Topgen Company Summary
Table 55. Topgen Melanoma Molecular Diagnostics Product Offerings
Table 56. Topgen Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Topgen Key News & Latest Developments
Table 58. Geneis Company Summary
Table 59. Geneis Melanoma Molecular Diagnostics Product Offerings
Table 60. Geneis Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Geneis Key News & Latest Developments
Table 62. Unitedgene Company Summary
Table 63. Unitedgene Melanoma Molecular Diagnostics Product Offerings
Table 64. Unitedgene Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Unitedgene Key News & Latest Developments
Table 66. Inmedi Company Summary
Table 67. Inmedi Melanoma Molecular Diagnostics Product Offerings
Table 68. Inmedi Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Inmedi Key News & Latest Developments
List of Figures
Figure 1. Melanoma Molecular Diagnostics Segment by Type in 2022
Figure 2. Melanoma Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Melanoma Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Melanoma Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Melanoma Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Melanoma Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Foundationmendicine Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mole Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Berryoncology Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gene+ Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Annoroad Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Topgen Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Geneis Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Unitedgene Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Inmedi Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
